American Renal Associates Holdings Inc 's ROA from the third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is American Renal Associates Holdings Inc 's ROA in the third quarter of 2020?
American Renal Associates Holdings Inc achieved a return on average assets (ROA) of 3.3 % in its third quarter of 2020, this is above ARA's average return on assets of 0.26%.
American Renal Associates Holdings Inc assets over the 12 months ending in its third quarter of 2020 are valued at $1,043 million

ROA decreased relative to the period ending Jun 30 2020, due to the decline in net income.

However, within the Healthcare sector 153 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2020 from 1257 to 1347.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter
Y / Y Total Assets Change	-8.17 %	-7.17 %	-0.89 %	-3.22 %	15.5 %
Y / Y Net Income Change	-24.9 %	188.6 %	-	-	-
Net Income (TTM) in million	34	39	29	26	5
Return On Assets (TTM)	3.3 %	3.63 %	2.67 %	2.4 %	0.47 %
ARA's Total Ranking	# 1347	# 1257	# 1552	# 2039	# 2674
Total Assets (TTM) in million	1,027	1,065	1,124	954	1,118
Seq. Total Assets Change	-3.62 %	-5.23 %	17.81 %	-14.66 %	-2.57 %
Seq. Net Income Change	-13.8 %	-	-	-46.42 %	231.26 %

ARA's 5 Years Annual ROA >> Back to ARA Management Effectiveness >> Compare ARA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 20
Sector	# 154
Overall	# 1322

Return On Assets Statistics
High	Average	Low
3.41 %	0.26 %	-4.08 %
(Jun 30 2020)		(Dec 31 2018)

Financial Statements
American Renal Associates Holdings Inc 's Assets	$ 1,027 million	ARA's Balance sheet
American Renal Associates Holdings Inc 's Income	$ 13 million	Quarterly ARA's Income Statement
ARA's Income by Division		See ARA's Income by Division

Annual Return On Assets	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	(Dec 31 2014) FY 2016	FY
Y / Y Total Assets Change	10.24 %	2.24 %	-6.95 %	-	-
Total Assets in million	1,087	986	964	1,036	0
Y / Y Net Income Change	16.37 %	-70.31 %	-8.16 %	-	-
Net Income in million	26	22	76	82	0
Annual Return On Assets	2.41 %	2.28 %	7.85 %	7.95 %	-

ARA's 5 Years Annual ROA >> Back to ARA Management Effectiveness >> Compare ARA ROA to its Competitors

Comment on ARA's ROA in the fiscal year ending 2019

In the fiscal year 2019 ROA improved to 2.41 % compared to prior year, due to annual net income growth of 16.37 % to $26.15 million, while value of American Renal Associates Holdings Inc 's overall assets grew just by 10.24 % to $1,086.79 million, compared to $1,086.79 a year before.

More Return On Assets Ratios
ARA's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ARA's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ARA's Competitors
Subscribers only: Roa for American Renal Associates Holdings Inc 's Suppliers
Subscribers only: Return On Assets for ARA's Customers

You may also want to know
ARA's Roi	ARA's Inventory Turnover Ratio	ARA's Growth Rates	ARA's Dividend Comparisons
	ARA's Profitability Ratios	ARA's Asset Turnover Ratio	ARA's Dividend Growth
ARA's Roe	ARA's Valuation Ratios	ARA's Financial Strength Ratios	ARA's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2020, within Healthcare Sector	ROA
Procyon Corporation	8.95 %
Quest Diagnostics Inc	8.88 %
Illumina Inc	8.73 %
Lemaitre Vascular Inc	8.45 %
Hca Healthcare Inc	8.34 %
Henry Schein Inc	8.18 %
Msa Safety Inc	8.00 %
Steris Plc	7.89 %
Haemonetics Corporation	7.87 %
Neogen Corporation	7.86 %
Nature s Sunshine Products inc	7.85 %
U S Physical Therapy Inc	7.69 %
Ufp Technologies Inc	7.67 %
Exelixis Inc	7.61 %
Dexcom Inc	7.58 %
Agilent Technologies inc	7.55 %
Cryo cell International Inc	7.39 %
Universal Health Services Inc	7.38 %
Biodelivery Sciences International Inc	7.16 %
China Health Industries Holdings Inc	7.04 %
Fonar Corporation	6.92 %
Emergent Biosolutions Inc	6.87 %
Antares Pharma Inc	6.69 %
Neurocrine Biosciences Inc	6.57 %
Acorda Therapeutics Inc	6.57 %
Globus Medical Inc	6.30 %
Ensign Group Inc	6.29 %
Luminex Corporation	6.25 %
Revvity Inc	6.24 %
Abbvie Inc	6.16 %

Date modified: 2026-09-18T13:11:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.